Mydriatic Agent
Sponsors
Eyenuk, Inc., Ural Telekomunikasyon Sanayi Ticaret Anonim Sirketi, RETINA-AI Health, Inc.
Conditions
Age-Related Macular DegenerationDiabetesDiabetic Eye ProblemsDiabetic Macular EdemaDiabetic RetinopathyEye DiseasesGlaucomaRetinal Vein Occlusion
Unknown Phase
Pilot Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool
CompletedNCT03078231
Start: 2017-02-17End: 2017-04-24Updated: 2018-07-30
Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool
CompletedNCT03112005
Start: 2017-04-17End: 2018-05-31Updated: 2018-07-30
Assessment of EyeArt Performance With Retinal Imaging Devices
CompletedNCT04302012
Start: 2019-12-18End: 2020-02-27Updated: 2021-07-08
Detection and Classification of Diabetic Retinopathy From Posterior Pole Images With A Deep Learning Model
CompletedNCT04805541
Start: 2022-02-01End: 2022-07-04Updated: 2024-07-15
Assessment of EyeArt Performance With Retinal Cameras
CompletedNCT04984200
Start: 2021-07-13End: 2022-08-19Updated: 2022-11-09
Validation Study of RETINA-AI Galaxy™ v2.0, an Automated Diabetic Retinopathy Screening Device
CompletedNCT05368623
Start: 2022-11-03End: 2023-03-31Updated: 2023-10-16
Detecting Eye Diseases Via Hybrid Deep Learning Algorithms From Fundus Images
CompletedNCT06213896
Start: 2023-03-01End: 2024-04-18Updated: 2024-05-14